Article
Dominating the Negative: How DNMT3A Mutations Contribute to AML Pathogenesis.
Cell stem cell - 5 Jan 2017
Challen Grant A
Abstract excerpt
Somatic mutations in DNMT3A are one of the most prevalent genetic abnormalities found in acute myeloid leukemia (AML) patients. A new study by Guryanova et al. sheds mechanistic insight into how the most common DNMT3A variant protein contributes to AML using a combination of mouse genetics and primary patient samples.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.